{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:50:04Z","timestamp":1760982604234},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11940-008-0024-y","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T14:15:30Z","timestamp":1210860930000},"page":"222-229","source":"Crossref","is-referenced-by-count":12,"title":["Myoclonus"],"prefix":"10.1007","volume":"10","author":[{"given":"Victoria C.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,16]]},"reference":[{"key":"24_CR1","first-page":"196","volume-title":"Movement Disorders","author":"C.D. Marsden","year":"1982","unstructured":"Marsden CD, Hallett M, Fahn S: The nosology and pathophysiology of myoclonus. In Movement Disorders. Edited by Marsden CD, Fahn S. London: Butterworth; 1982:196\u2013248."},{"key":"24_CR2","first-page":"1","volume-title":"Advances in Neurology","author":"S. Fahn","year":"1986","unstructured":"Fahn S: Definition and classification of myoclonus. In Advances in Neurology. Edited by Fahn S. New York: Raven Press; 1986:1\u20135."},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/brain\/117.4.775","volume":"117","author":"G. Deuschl","year":"1994","unstructured":"Deuschl G, Toro C, Valls-Sol\u00e9 J, et al.: Symptomatic and essential palatal tremor. 1. Clinical, physiological, and MRI analysis. Brain 1994, 117:775\u2013788.","journal-title":"Brain"},{"key":"24_CR4","first-page":"197","volume":"114","author":"P. Brown","year":"1991","unstructured":"Brown P, Thompson PD, Rothwell JC, et al.: Axial myoclonus of propriospinal origin. Brain 1991, 114:197\u2013214.","journal-title":"Brain"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archneurpsyc.1938.02270110122008","volume":"40","author":"R.R. Grinker","year":"1938","unstructured":"Grinker RR, Serota H, Stein SI: Myoclonic epilepsy. Arch Neurol Psychiatry 1938, 40:968\u2013980.","journal-title":"Arch Neurol Psychiatry"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.20234","volume":"31","author":"H. Shibasaki","year":"2005","unstructured":"Shibasaki H, Hallett M: Electrophysiological studies of myoclonus. Muscle Nerve 2005, 31:157\u2013174.","journal-title":"Muscle Nerve"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neucli.2006.12.008","volume":"36","author":"J.P. Lefaucheur","year":"2006","unstructured":"Lefaucheur JP: Myoclonus and transcranial magnetic stimulation [review]. Neurophysiol Clin 2006, 36:293\u2013297.","journal-title":"Neurophysiol Clin"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/mds.21562","volume":"22","author":"E. Roze","year":"2007","unstructured":"Roze E, Apartis E, Vidailhet M, et al.: Propriospinal myoclonus: utility of magnetic resonance diffusion tensor imaging and fiber tracking. Mov Disord 2007, 22:1506\u20131509.","journal-title":"Mov Disord"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.parkreldis.2007.07.001","volume":"13","author":"K.K. Tai","year":"2007","unstructured":"Tai KK, Bhidayasiri R, Truong DD: Post-hypoxic animal model of myoclonus. Parkinsonism Relat Disord 2007, 13:377\u2013381.","journal-title":"Parkinsonism Relat Disord"},{"key":"24_CR10","first-page":"107","volume":"26","author":"M.H. Woert Van","year":"1979","unstructured":"Van Woert MH, Rosenbaum D: L-5-hydroxytryptophan therapy in myoclonus. Adv Neurol 1979, 26:107\u2013115.","journal-title":"Adv Neurol"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ana.410070611","volume":"7","author":"L.J. Thal","year":"1980","unstructured":"Thal LJ, Sharpless NS, Wolfson L, et al.: Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Ann Neurol 1980, 7:570\u2013576.","journal-title":"Ann Neurol"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00702-007-0788-3","volume":"114","author":"K.K. Tai","year":"2007","unstructured":"Tai KK, Truong DD: Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. J Neural Transm 2007, 114:1547\u20131551.","journal-title":"J Neural Transm"},{"key":"24_CR13","first-page":"329","volume":"67","author":"M.R. Pranzatelli","year":"1995","unstructured":"Pranzatelli MR, Nadi NS: Mechanism of action of antiepileptic and antimyoclonic drugs. Adv Neurol 1995, 67:329\u2013360.","journal-title":"Adv Neurol"},{"key":"24_CR14","first-page":"253","volume":"3","author":"J.A. Obeso","year":"1995","unstructured":"Obeso JA: Therapy of myoclonus. Clin Neurosci 1995, 3:253\u2013257.","journal-title":"Clin Neurosci"},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.20530","volume":"20","author":"P. Striano","year":"2005","unstructured":"Striano P, Manganelli F, Boccella P: Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 2005, 20:1610\u20131655.","journal-title":"Mov Disord"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.57.6.1112","volume":"57","author":"S. Frucht","year":"2001","unstructured":"Frucht S, Louis E, Chuang C, et al.: A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology 2001, 57:1112\u20131114.","journal-title":"Neurology"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","volume":"45","author":"A. Magaudda","year":"2004","unstructured":"Magaudda A, Gelisse P, Genton P: Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations. Epilepsia 2004, 45:678\u2013681.","journal-title":"Epilepsia"},{"key":"24_CR18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11096-006-9039-1","volume":"29","author":"S. Papacostas","year":"2007","unstructured":"Papacostas S, Kkolou E, Papathanasiou E: Levetiracetam in three cases of progressive myoclonus epilepsy. Pharm World Sci 2007, 29:164\u2013166.","journal-title":"Pharm World Sci"},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/jnnp.64.3.344","volume":"64","author":"M. Koskiniemi","year":"1998","unstructured":"Koskiniemi M, Van Vleymen B, Hakamies L, et al.: Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the safety and efficacy of three dosages of oral piracetam with placebo. J Neurol Neurosurg Psychiatry 1998, 64:344\u2013348.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"24_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mds.870080112","volume":"8","author":"P. Brown","year":"1993","unstructured":"Brown P, Steiger MJ, Thompson PD, et al.: Effectiveness of piracetam in cortical myoclonus. Mov Disord 1993, 8:63\u201368.","journal-title":"Mov Disord"},{"key":"24_CR21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.870110615","volume":"11","author":"A. Ikeda","year":"1996","unstructured":"Ikeda A, Shibasaki H, Tashiro K, et al.: Clinical trial of piracetam in patients with myoclonus: nationwide multi-institutional study in Japan. The Myoclonus\/Piracetam Study Group. Mov Disord 1996, 11:691\u2013700.","journal-title":"Mov Disord"},{"key":"24_CR22","first-page":"49","volume-title":"Advances in Neurology","author":"S. Fahn","year":"1979","unstructured":"Fahn, S: Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen. In Advances in Neurology. Edited by Fahn S. New York: Raven Press, 1979:49\u201384."},{"issue":"Suppl1","key":"24_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870150702","volume":"15","author":"S. Frucht","year":"2000","unstructured":"Frucht S: The clinical spectrum of posthypoxic myoclonus. Mov Disord 2000, 15(Suppl 1):2\u20137.","journal-title":"Mov Disord"},{"key":"24_CR24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/mds.20452","volume":"20","author":"S. Frucht","year":"2005","unstructured":"Frucht S, Bordelon Y, Houghton WH: Marked amelioration of alcohol-responsive posthypoxic myoclonus by gamma-hydroxybutyric acid (Xyrem). Mov Disord 2005, 20:745\u2013751.","journal-title":"Mov Disord"},{"key":"24_CR25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/archneur.1986.00520100039012","volume":"43","author":"J. Jankovic","year":"1986","unstructured":"Jankovic J, Pardo R: Segmental myoclonus. Clinical and pharmacologic study. Arch Neurol 1986, 43:1025\u20131031.","journal-title":"Arch Neurol"},{"key":"24_CR26","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/mds.20217","volume":"19","author":"A. Siniscali","year":"2004","unstructured":"Siniscali A, Mancuso F, Russo E, et al.: Spinal myoclonus responsive to topiramate. Mov Disord 2004, 19:1380\u20131381.","journal-title":"Mov Disord"},{"key":"24_CR27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.21469","volume":"22","author":"A. Abraham","year":"2007","unstructured":"Abraham A, Cogan E, Melamed E, et al.: Successful treatment of truncal myoclonus. Mov Disord 2007, 22:1055\u20131056.","journal-title":"Mov Disord"},{"key":"24_CR28","first-page":"672","volume":"27","author":"E. Krause","year":"2006","unstructured":"Krause E, Leunig A, Klopstock T, G\u00fcrkov R: Treatment of essential palatal myoclonus in a 10-year-old girl with botulinum neurotoxin. Otol Neurotol 2006, 27:672\u2013675.","journal-title":"Otol Neurotol"},{"key":"24_CR29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00415-006-0039-9","volume":"253","author":"S.E. Penney","year":"2006","unstructured":"Penney SE, Bruce IA, Saeed SR: Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol 2006, 253:857\u2013860.","journal-title":"J Neurol"},{"key":"24_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neucli.2006.12.001","volume":"36","author":"G. Rubboli","year":"2006","unstructured":"Rubboli G, Tassinari CA. Negative myoclonus. An overview of its clinical features, pathophysiological mechanisms, and management [review]. Neurophysiol Clin 2006, 36:337\u2013343.","journal-title":"Neurophysiol Clin"},{"key":"24_CR31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1034\/j.1600-0404.2003.02141.x","volume":"107","author":"P. Gelisse","year":"2003","unstructured":"Gelisse P, Crespel A, Genton P, Baldy-Moulinier M: Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol Scand 2003, 107:302\u2013303.","journal-title":"Acta Neurol Scand"},{"key":"24_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2007-973530","volume":"29","author":"H. Oguni","year":"1998","unstructured":"Oguni H, Uehara T, Tanaka T, et al.: Dramatic effect of ethosuximide on epileptic negative myoclonus: implications for the neurophysiological mechanism. Neuropediatrics 1998, 29:29\u201334.","journal-title":"Neuropediatrics"},{"key":"24_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00298440","volume":"8","author":"S.M. Pueschel","year":"1992","unstructured":"Pueschel SM, Friedman JH, Shetty T: Myoclonic dystonia. Childs Nerv Syst 1992, 8:61\u201366.","journal-title":"Childs Nerv Syst"},{"key":"24_CR34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/mds.21297","volume":"22","author":"A. Misbahuddin","year":"2007","unstructured":"Misbahuddin A, Placzek M, Lennox G, et al.: Myoclonusdystonia syndrome with severe depression is caused by an exon-skipping mutation in the \u03b5-sarcoglycan gene. Mov Disord 2007, 22:1173\u20131175.","journal-title":"Mov Disord"},{"key":"24_CR35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2","volume":"46","author":"T.G. Nygaard","year":"1999","unstructured":"Nygaard TG, Raymond D, Chen C, et al.: Localization of a gene for myoclonus-dystonia to chromosome 7q21\u2013q31. Ann Neurol 1999, 46:794\u2013798.","journal-title":"Ann Neurol"},{"key":"24_CR36","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/mds.20605","volume":"20","author":"S.J. Frucht","year":"2005","unstructured":"Frucht SJ, Boredlon Y, Houghton WH, et al.: Pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 2005, 20:1330\u20131337.","journal-title":"Mov Disord"},{"key":"24_CR37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mds.20030","volume":"19","author":"L. Cif","year":"2004","unstructured":"Cif L, Valente EM, Hemm S, et al.: Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 2004, 19:724\u2013727.","journal-title":"Mov Disord"},{"key":"24_CR38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1136\/jnnp.2004.039248","volume":"76","author":"C.M. Magari\u00f1os-Ascone","year":"2005","unstructured":"Magari\u00f1os-Ascone CM, Regidor I, Martinez-Castrillo JC, et al.: Pallidal stimulation relieves myoclonus-dystonia syndrome. J Neurol Neurosurg Psychiatry 2005, 76:989\u2013991.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"24_CR39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/mds.1119","volume":"16","author":"T. Trottenberg","year":"2001","unstructured":"Trottenberg T, Meissner W, Kabus C, et al.: Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome. Mov Disord 2001, 16:769\u2013771.","journal-title":"Mov Disord"},{"key":"24_CR40","unstructured":"Physicians\u2019 Desk Reference, edn 62. Montvale, NJ: Thomson PDR; 2008."},{"key":"24_CR41","unstructured":"Drug Topics Red Book, edn 111. Montvale, NJ: Medical Economics; 2007."},{"key":"24_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/mds.21320","volume":"22","author":"R. Mondria","year":"2007","unstructured":"Mondria R, de Gier HHW, Boon AJW: New device to control combined lingual and palatal myoclonus. Mov Disord 2007, 22:573\u2013575.","journal-title":"Mov Disord"},{"key":"24_CR43","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S1474-4422(04)00880-4","volume":"3","author":"J. Caviness","year":"2004","unstructured":"Caviness J, Brown P: Myoclonus: current concepts and recent advances. Lancet Neurol 2004, 3:598\u2013607.","journal-title":"Lancet Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0024-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-008-0024-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0024-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:53Z","timestamp":1559437013000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-008-0024-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s11940-008-0024-y","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}